New Computer Models Open Door to Far More Targeted Antibiotics

With antibiotic resistance a growing problem, University of Virginia School of Medicine researchers have developed cutting-edge computer models that could give the disease-fighting drugs a laser-like precision to target only specific bacteria in specific parts of the body.

As it stands, antibiotics kill bacteria indiscriminately. Because the drugs are used so widely, increasing numbers of dangerous bugs are growing resistant, threatening one of modern medicine’s most important weapons against disease.

UVA's new approach, on the other hand, would dramatically limit how often bacteria are exposed to antibiotics, reducing the chance they could become resistant to antibiotics. Further, the approach would represent a significant step forward for precision medicine, allowing doctors to better tailor treatments to individual patients’ needs. Instead of taking an antibiotic that kills bacteria regardless of whether helpful or harmful, patients could be given antibiotics that target specific bacteria causing a specific problem in a specific area of the body.

"Many biomedical challenges are incredibly complex, and computer models are emerging as a powerful tool for tackling such problems," said researcher Jason Papin, PhD, of UVA's Department of Biomedical Engineering. "We're hopeful that these computer models of the molecular networks in bacteria will help us develop new strategies to treat infections."

UVA's new approach was made possible by a herculean effort by Papin, PhD student Emma Glass and their collaborators. Working with Andrew Warren, PhD, of UVA's Biocomplexity Institute, the researchers in Papin’s lab developed sophisticated computer models of every human bacterial pathogen with sufficient genetic information available.

Glass then analyzed all those models and identified shared traits among the bacteria. This analysis yielded the discovery that bacteria in certain parts of the body, such as the stomach, tended to share metabolic properties. Basically, where they live shapes how they function.

"Using our computer models we found that the bacteria living in the stomach had unique properties," Glass said. "These properties can be used to guide design of targeted antibiotics, which could hopefully one day slow the emergence of resistant infections."

The shared similarities among the microbes in different locales could be the Achilles' heel for harmful bacteria in our bodies. With further research, doctors may be able to target specific types of bacteria in specific areas, reducing the need for broad-spectrum antibiotics.

Putting their computer-modeling approach to the test, Papin and his team have already found that they could inhibit the growth of harmful stomach bugs in lab experiments. That’s a promising sign for the future potential of their computer-modeling approach.

"We still have much to do to test these ideas for other bacteria and types of infections," Papin said. "but this work shows the incredible promise of data science and computer modeling for tackling some of the most important problems in biomedical research."

Glass EM, Dillard LR, Kolling GL, Warren AS, Papin JA.
Niche-specific metabolic phenotypes can be used to identify antimicrobial targets in pathogens.
PLoS Biol. 2024 Nov 18;22(11):e3002907. doi: 10.1371/journal.pbio.3002907

Most Popular Now

Open Medical Works with Moray's Dig…

Open Medical is working with the Digital Health & Care Innovation Centre’s Rural Centre of Excellence on a referral management plan, as part of a research and development scheme to...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Reorganisation, Consolidation, and Cuts:…

NHS England has been downsized and abolished. Integrated care boards have been told to change function, consolidate, and deliver savings. Trusts are planning big cuts. The Highland Marketing advisory board...

AI-Human Task-Sharing could Cut Mammogra…

The most effective way to harness the power of artificial intelligence (AI) when screening for breast cancer may be through collaboration with human radiologists - not by wholesale replacing them...

AI Tool Uses Face Photos to Estimate Bio…

Eyes may be the window to the soul, but a person's biological age could be reflected in their facial characteristics. Investigators from Mass General Brigham developed a deep learning algorithm...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...

Philips Future Health Index 2025 Report …

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today unveiled its 2025 Future Health Index U.S. report, "Building trust in healthcare AI," spotlighting the state of...

AI-Powered Precision: Unlocking the Futu…

A team of researchers from the Department of Diagnostic and Therapeutic Ultrasonography at the Tianjin Medical University Cancer Institute & Hospital, have published a review in Cancer Biology & Medicine...

AI Model Improves Delirium Prediction, L…

An artificial intelligence (AI) model improved outcomes in hospitalized patients by quadrupling the rate of detection and treatment of delirium. The model identifies patients at high risk for delirium and...

Building Trust in Artificial Intelligenc…

A new review, published in the peer-reviewed journal AI in Precision Oncology, explores the multifaceted reasons behind the skepticism surrounding artificial intelligence (AI) technologies in healthcare and advocates for approaches...

SALSA: A New AI Tool for the Automated a…

Investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group, led by Raquel Perez-Lopez, have developed SALSA (System for Automatic Liver tumor Segmentation And detection), a fully automated deep...